Trends, Challenges, and Opportunities for Enterprise Audio Capture

Companies have been using audio capture for decades, and it’s seen many evolutions. Now, organizations are using it across the enterprise to drive improvement and insights.

To get a view of the industry and what’s new, MarketScale Radio host Daniel Litwin spoke with Steve Kaiser, Co-Founder and CEO of OrecX, a developer of call recording software.

“The beginnings of call recording in business were call centers and help desk. That’s morphed into recording all calls across the company to learn from them. It’s now as ubiquitous as voicemail,” Kaiser said.

This voice data has meaning when companies can add structure and meaning to it. While many organizations have this feature in a set from a communication provider, the pandemic exposed the lack of agility around operations and communications.

Kaiser explained that businesses have two choices for adopting this technology—open, modern systems or black boxes. The choice is now available, much in part due to the cloud. “The advent of the cloud and infrastructure-as-a-service enabled organizations to spring forward in the design and capture of audio and making meaning out of it.”

This new structure also fits a new workforce that’s no longer only on-premises. Ideally, a company will want to use a single platform to handle recordings, no matter where the worker is.

“With black box, you can’t do cloud and on-premises together. Open systems do this well. A black-box solution will also incur extraction fees just to access the data you already own. With a modern, open system, it’s agile and has a collaborative benefit. You also have access to data and can share it with anyone and create value,” Kaiser explained.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Evolving Biomarkers: Charting the Future of Precision Medicine
April 19, 2025

In a rapidly shifting landscape of personalized medicine, biomarkers have become central to shaping the way drug development and clinical trials unfold. From predicting therapeutic response to identifying optimal patient populations, the complexity and scope of biomarker use has increased alongside technological advances. A key success story like the BCR-ABL biomarker in chronic myeloid leukemia…

Read More
Drug Discovery
Exploring Artificial Intelligence in Drug Discovery
April 19, 2025

Artificial intelligence is rapidly reshaping the drug discovery process, moving from augmenting research to actively driving innovation. As biotech companies face soaring R&D costs and long development cycles, AI promises a breakthrough: slashing drug development time by nearly half while improving accuracy in identifying promising compounds. With global pharmaceutical R&D spending projected to exceed $230…

Read More
KRAS
Pioneering Strategies to Unlocking the Potential of KRAS
April 18, 2025

Once labeled “undruggable,” KRAS has emerged as one of oncology’s most promising—yet complex—targets. With nearly 90% of pancreatic cancers and 30-40% of lung and colorectal cancers harboring KRAS mutations, the need for effective therapies is urgent. Recent FDA approvals of KRAS G12C inhibitors have signaled a new era, but the rise of resistance and diverse…

Read More
Polygon: Transforming Project Visions into Success Stories
April 18, 2025

Every successful project begins with a vision. The journey from ideation to fruition might seem daunting, but with the right toolkit and a trusted partner, your goals are within reach. This is where Polygon steps in. Tailoring solutions to match your unique needs, we ensure your projects kick start on a robust footing and…

Read More